Zhanguo Li

Active 2008–2026

118
Papers
18,038
Citations
44
h-index
103
i10-index

Citations

Citations per year for Zhanguo Li1971: 1 citations2007: 1 citations2008: 1 citations2010: 1 citations2011: 13 citations2012: 35 citations2013: 43 citations2014: 78 citations2015: 115 citations2016: 122 citations2017: 149 citations2018: 156 citations2019: 613 citations2020: 813 citations2021: 978 citations2022: 760 citations2023: 596 citations2024: 951 citations2025: 474 citations2026: 21 citations1972–2006: no citations, so these years are not shown2009: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,379 citing papers, 15.1% of this breakdownChina: 1,272 citing papers, 14% of this breakdownUnited Kingdom: 662 citing papers, 7.3% of this breakdownGermany: 446 citing papers, 4.9% of this breakdownItaly: 429 citing papers, 4.7% of this breakdownNetherlands: 408 citing papers, 4.5% of this breakdownJapan: 404 citing papers, 4.4% of this breakdownFrance: 374 citing papers, 4.1% of this breakdownAustralia: 265 citing papers, 2.9% of this breakdownCanada: 252 citing papers, 2.8% of this breakdownSpain: 234 citing papers, 2.6% of this breakdownSweden: 189 citing papers, 2.1% of this breakdown
0%15.1%Other 30.6%

Fields

  • Medicine66.5%
  • Immunology and Microbiology15.7%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Neuroscience1%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Engineering0.7%
  • Other3%

Topics

  • Rheumatoid Arthritis Research and Therapies14.8%
  • Systemic Lupus Erythematosus Research6%
  • Autoimmune and Inflammatory Disorders Research4.7%
  • Spondyloarthritis Studies and Treatments4.5%
  • T-cell and B-cell Immunology4.3%
  • Immune Cell Function and Interaction3.6%
  • Other62.1%

Coauthors

All papers

Open in search
  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B. McInnes, Eduardo Mysler, Peter Nash, Gyula Poór, Gorica Ristić, Felice Rivellese, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Nikolay Stoilov, Anja Strangfeld, Annette H M van der Helm–van Mil, Elsa van Duuren, T. P. M. Vliet Vlieland, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 cited by 1,788

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 5,775

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 cited by 2,766

  4. Intestinal butyrate-metabolizing species contribute to autoantibody production and bone erosion in rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2022 cited by 222

  5. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhanguo Li - Annals of the Rheumatic Diseases 2019 cited by 337

  6. Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Di Yu, Zhanguo Li - Nature Medicine 2016 cited by 572

  7. Circulating Precursor CCR7loPD-1hi CXCR5+ CD4+ T Cells Indicate Tfh Cell Activity and Promote Antibody Responses upon Antigen Reexposure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2013 cited by 654

  8. Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, DaeYoung Yu, Chetan S. Karyekar, Chak Sing Lau, Julie A. Monk, Mandana Nikpour, Alberta Hoi, Eric F. Morand - The Lancet Rheumatology 2022 cited by 67

  9. A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2017 cited by 182

  10. Targeting TFH cells in human diseases and vaccination: rationale and practice

    Authors: , , , , - Nature Immunology 2022 cited by 135

  11. Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianping Guo, Wanli Liu, Wenbin Zhang, Alexander Jacob, Julian L. Ambrus, Changhai Ding, Di Yu, Xiaolin Sun, Zhanguo Li - JAMA Network Open 2022 cited by 88

  12. Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis

    Authors: , , , , , , , , , , , , , - Annals of Internal Medicine 2013 cited by 447

  13. Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice

    Authors: , , , , , , , , , , , , , , , , - Phytomedicine 2023 cited by 36

  14. 2018 update of the APLAR recommendations for treatment of rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , , , , - International Journal of Rheumatic Diseases 2019 cited by 176

  15. Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity

    Authors: , , - Clinical & Experimental Immunology 2021 cited by 106

  16. Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Signal Transduction and Targeted Therapy 2022 cited by 69

  17. Genetic association of PRDM1-ATG5 intergenic region and autophagy with systemic lupus erythematosus in a Chinese population

    Authors: , , , , , , , , - Annals of the Rheumatic Diseases 2011 cited by 235

  18. An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lei Zhang, Zhanlong Shen, Wanli Liu - Journal of Clinical Investigation 2022 cited by 44

  19. Myeloid-derived suppressor cells have a proinflammatory role in the pathogenesis of autoimmune arthritis

    Authors: , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 160

  20. Hypoxia‐inducible factor‐1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis

    Authors: , , , , , , , , , , , - European Journal of Immunology 2015 cited by 90

  21. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus

    Authors: , - Lara D. Veeken 2023 cited by 50

  22. LAG3 (CD223) and autoimmunity: Emerging evidence

    Authors: , , , , - Journal of Autoimmunity 2020 cited by 50

  23. The metabolic hormone leptin promotes the function of TFH cells and supports vaccine responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lilin Ye, Steven Rockman, Michelle A. Linterman, Katherine Kedzierska, Nan Shen, Liwei Lu, Di Yu - Nature Communications 2021 cited by 42

  24. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, Sandra Navarra, Chak Sing Lau, Alberta Hoi, Eric F. Morand, Mandana Nikpour, Aisha Lateef - The Lancet Rheumatology 2023 cited by 28